82.68
Inhibrx Biosciences Inc Borsa (INBX) Ultime notizie
Inhibrx Biosciences stock hits all-time high at 87.4 USD By Investing.com - Investing.com Australia
Inhibrx Biosciences stock hits all-time high at 87.4 USD - Investing.com India
Discipline and Rules-Based Execution in INBX Response - news.stocktradersdaily.com
Will Inhibrx Biosciences Inc. stock deliver shareholder value2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com
What high frequency data says about Inhibrx Biosciences Inc.2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
How high can Inhibrx Biosciences Inc. stock go2025 Valuation Update & Risk Controlled Stock Pick Alerts - newser.com
Multi factor analysis applied to Inhibrx Biosciences Inc.Weekly Gains Report & Weekly Watchlist for Hot Stocks - newser.com
Inhibrx Biosciences Inc. stock daily chart insights2025 Technical Patterns & Free Community Supported Trade Ideas - newser.com
How to recover losses in Inhibrx Biosciences Inc. stock2025 Market Outlook & Safe Capital Growth Tips - newser.com
Inhibrx Biosciences stock rating maintained at Market Perform by Citizens - Investing.com South Africa
Is Inhibrx Biosciences Inc. stock a buy in volatile marketsWeekly Trend Recap & Verified Stock Trade Ideas - newser.com
Will Inhibrx Biosciences Inc. stock pay special dividendsJuly 2025 Recap & Fast Gain Swing Alerts - newser.com
Inhibrx Biosciences Inc (INBX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Why Inhibrx Biosciences Inc. stock appeals to analystsJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
What Wall Street predicts for Inhibrx Biosciences Inc. stock priceQuarterly Trade Summary & Weekly Top Gainers Trade List - newser.com
Press Release: Inhibrx Reports Third Quarter 2025 Financial Results - 富途牛牛
Inhibrx Misses Estimates Even As New Cancer Drug Shows Promise - Finimize
Inhibrx Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Earnings Flash (INBX) Inhibrx Biosciences Posts Q3 Loss $2.28 a Share - MarketScreener
Inhibrx Biosciences' Q3 net loss widens, misses EPS estimates - MarketScreener
Inhibrx Biosciences, Inc. SEC 10-Q Report - TradingView
Inhibrx Reports Third Quarter 2025 Financial Results - PR Newswire
[8-K] Inhibrx Biosciences, Inc. Reports Material Event | INBX SEC FilingForm 8-K - Stock Titan
[10-Q] Inhibrx Biosciences, Inc. Quarterly Earnings Report | INBX SEC FilingForm 10-Q - Stock Titan
Inhibrx’s Phase 2 Study on INBRX-109: A Potential Breakthrough in Chondrosarcoma Treatment - MSN
Inhibrx supports CTOS2025 spotlight on chondrosarcoma - Traders Union
Behavioral Patterns of INBX and Institutional Flows - news.stocktradersdaily.com
What does recent volatility data suggest for Inhibrx Biosciences Inc.Quarterly Profit Review & Consistent Income Trade Ideas - newser.com
Is Inhibrx Biosciences Inc. stock resilient to inflationEarnings Overview Summary & Accurate Intraday Trading Signals - newser.com
Tick level data insight on Inhibrx Biosciences Inc. volatilityJuly 2025 Recap & AI Enhanced Trading Alerts - newser.com
Will Inhibrx Biosciences Inc. stock benefit from sector rotation2025 AllTime Highs & Free Daily Entry Point Trade Alerts - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):